Centrus Energy Corp. — FY 2017 Form 10-K
Reporting period: Fiscal year ended December 31, 2017. Amounts are in U.S. dollars; financial figures are in millions unless stated otherwise. The filing also reports fourth-quarter results.
Business context
Centrus supplies low-enriched uranium (LEU) and uranium to nuclear utilities and performs technical and engineering services, including American Centrifuge research and testing under a contract with UT-Battelle. LEU generated about 89% of 2017 revenue. The company had ceased commercial enrichment production and relied on inventory, suppliers and spot purchases to fulfill customer deliveries. Management cited a persistently oversupplied nuclear-fuel market and historically low enrichment prices.
Financial performance and liquidity
| Metric | FY 2017 | FY 2016 |
|---|---|---|
| Revenue | $218.4 | $311.3 |
| Gross profit / margin | $56.8 / 26.0% | $45.1 / 14.5% |
| Operating loss | $(17.5) | $(61.7) |
| Net income (loss) | $12.2 | $(67.0) |
| Net income (loss) allocable to common shareholders | $5.3 | $(67.0) |
| Cash from operating activities | $(25.1) | $37.7 |
| Cash and cash equivalents at year-end | $208.8 | $260.7 |
| Working capital | $163.5 | $234.9 |
| Total liabilities / stockholders’ deficit | $894.2 / $(218.9) | $949.6 / $(236.1) |
- LEU revenue fell 28% to $195.4, reflecting a 21% decline in SWU sales volume, a 4% decline in average billed SWU price and no uranium revenue, versus $14.3 in 2016. Contract services revenue fell 40% to $23.0.
- Gross profit rose despite lower revenue, partly because cost of sales declined and retiree-benefit remeasurement produced a $23.1 credit in LEU cost of sales, versus a $4.2 charge in 2016. Excluding legacy costs and credits, LEU gross margin was 18.5%, compared with 16.2%.
- Net income included a $33.6 gain on the February 2017 debt exchange. It also benefited from lower advanced-technology and decommissioning costs and lower interest expense; operating results remained loss-making.
- Fourth-quarter revenue was $116.9 and net income was $35.5. Revenue is seasonal and depends on delivery timing.
- Operating cash flow turned negative, while inventory fell $44.7 and customer receivables increased $27.0. Investing activities provided $4.2, including proceeds from asset sales; financing activities used $31.0.
- Reported total debt was $163.6, including $157.5 classified as long-term and $6.1 current. The $132.4 carrying value of the 8.25% Notes includes future interest payments; principal was $74.3. The 8% PIK Toggle Notes had $31.3 principal outstanding and mature in September 2019, subject to possible extension if conditions are met.
Material changes and notable items
- In February 2017, Centrus exchanged $204.9 of 8% PIK Toggle Notes for $74.3 principal of 8.25% Notes due 2027, Series B preferred stock and $27.6 cash. The transaction substantially reduced note principal but left cumulative preferred dividends and continuing debt obligations.
- Year-end cash declined $51.9. Management expected 2018 cash to decrease further, mainly due to supply-purchase timing and higher required postretirement-benefit contributions.
- The sales order book was $1.3 billion at year-end, down from $1.4 billion. Management estimated about 14% was at risk from American Centrifuge deployment milestones or customer financial condition, versus about 5% a year earlier.
- The Piketon demonstration cascade decommissioning was mostly complete. Remaining estimated D&D costs were $1.0; separate lease-termination costs were estimated at $0.8. Maintaining the demobilized facility through its June 2019 lease end was expected to cost about $20.0.
- A January 2018 DOE settlement resolved specified contract claims for $24.0, comprising about $19.3 in previously unapplied government credits and $4.7 cash. Centrus expected to recognize about $9.5 of revenue in the first quarter of 2018. A separate $42.8 pension and postretirement-cost claim remained unresolved and fully valuation-allowanced.
- Management reported that the previously identified material weakness in controls over D&D estimates was remediated by December 31, 2017. Management also concluded disclosure controls and internal control over financial reporting were effective; the auditor’s financial-statement opinion was unqualified.
Guidance, risks and management commentary
- For 2018, management forecast SWU and uranium revenue of $150–$175, total revenue of $175–$200 and year-end cash of $100–$125. It expected more than half of annual revenue in the fourth quarter and cited lower average sales prices as newer-market contracts contribute more revenue.
- Management said it expected adequate liquidity for at least 12 months from the filing date. This outlook depended on customer deliveries and payments, supply purchases, government funding and benefit-plan contributions.
- Key risks include persistent market oversupply and price pressure; concentration in a small number of utility customers; uncertainty in customer delivery schedules and contract retention; dependence on TENEX and Russian import quotas and trade policy; and the possibility that committed supply costs exceed achievable sales prices.
- Other material risks include substantial pension and postretirement obligations, debt maturities and interest, customer credit issues, limited American Centrifuge funding, DOE/NRC requirements, and the risk of added restrictions on uranium imports. The filing also describes a U.S. national-security review of uranium imports initiated after year-end.
- The federal tax-rate reduction enacted in December 2017 led to a provisional $288.9 deferred-tax remeasurement, offset by a valuation allowance, with no net impact on the 2017 tax provision. The company reported a $440.7 valuation allowance against net deferred taxes and $789.7 of federal NOLs, subject to applicable limitations.
Investor facts to verify
- Whether 2018 revenue and cash guidance was achieved, particularly given the expected fourth-quarter concentration and cash outflows.
- Whether Centrus could resell all committed TENEX supply at prices and within markets that cover procurement costs, and how import restrictions or trade actions affected deliveries.
- Whether the $1.3 billion order book converted into revenue as projected, and whether customer financial distress or contract milestones reduced its value.
- Actual pension and postretirement contributions, funded status and sensitivity to discount rates, investment returns and healthcare costs.
- The final outcome and accounting treatment of the DOE settlement and the separate pension-cost claim, along with costs to complete Piketon decommissioning and facility return.
- Debt principal, cash interest requirements, PIK accruals, preferred-stock cumulative dividends and any conditions affecting the 8% Notes’ maturity or guarantee.